Baystreet Staff - Friday, September 30, 2011 Amorfix Life Sciences 10:03 AM EST - Amorfix Life Sciences : announced it has achieved 85% specificity and sensitivity with its EP-AD CSF Diagnostic Test. Amorfix Life Sciences shares T.AMF are trading up $0.025 at $0.26.